Cargando…

Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients

BACKGROUND: Following the paucity of safety reports in the use of Artemisinin-Based Combination Therapies (ACTs) plus paracetamol, the study assessed safety potential of artemether-lumefantrine (ALP), artesunate-amodiaquine (AAP), artesunate-mefloquine (AMP), artesunate-sulphadoxine-pyrimethamine (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghahowa, S.E., Ozolua, R.I., Bafor, E.E., Obarisiagbon, P., Isah, A.O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649067/
https://www.ncbi.nlm.nih.gov/pubmed/34926171
http://dx.doi.org/10.1016/j.toxrep.2021.11.007
_version_ 1784610917595480064
author Aghahowa, S.E.
Ozolua, R.I.
Bafor, E.E.
Obarisiagbon, P.
Isah, A.O.
author_facet Aghahowa, S.E.
Ozolua, R.I.
Bafor, E.E.
Obarisiagbon, P.
Isah, A.O.
author_sort Aghahowa, S.E.
collection PubMed
description BACKGROUND: Following the paucity of safety reports in the use of Artemisinin-Based Combination Therapies (ACTs) plus paracetamol, the study assessed safety potential of artemether-lumefantrine (ALP), artesunate-amodiaquine (AAP), artesunate-mefloquine (AMP), artesunate-sulphadoxine-pyrimethamine (ASPP) and dihydroartemisinin-piperaquine (DHPP) combination with paracetamol in malaria patients. METHODS: ACTs and paracetamol were administered concomitantly in conventional doses/regimen to randomly selected patients. Blood samples were collected from the ante-cubital vein before and after completion of therapies. Toxicity markers such as weights, glucose, lipids, renal electrolytes, liver enzymes and haematological indices were assessed using standard protocols. RESULTS: The total numbers of participants were 57 patients. Male to female ratio was 1:1.1. Mean body weight and ages were 59.19 ± 1.39 kg and 42.86 ± 1.32 years respectively. The mean temperatures prior to and after therapy were 37.49 ± 1.02 °C and 37.50 ± 0.17 °C respectively. Mean parasitaemia before the commencement of therapy was 6282 ± 21.01 parasites/μl. Out of thirty-seven toxicological indices evaluated, twenty–four were significantly altered by ACTs plus paracetamol (P < 0.05). Increased serum toxicity markers due to the drug combinations were glucose (AAP, AMP), urea (ALP, ASPP), bicarbonate ion (ALP, AAP, AMP, ASPP), chloride ion (ALP, AAP, AMP), creatinine (ALP, AAP, AMP, ASPP), alkaline phosphatase (ALP, AAP), aspartate aminotransferase and alanine aminotransferase (ALP, AAP, AMP, ASPP, DHPP), total protein (AMP, DHPP) and albumin (AMP, DHPP). Decreased serum toxicity markers due to the drugs were glucose (ALP, ASPP, DHPP), urea (AMP), bicarbonate ion (DHPP), chloride ion (ASPP, DHPP), creatinine (DHPP), alkaline phosphatase (AMP, ASPP, DHPP), total protein (ALP, AAP, and ASPP) and albumin (ALP, AAP, ASPP). Altered haematological indices were white blood cells, red blood cells, mean cell haemoglobin and platelets. CONCLUSION: Since ACTs plus paracetamol altered human system, discrete selection is essential in managing uncomplicated malaria most especially in patients with co-morbid conditions.
format Online
Article
Text
id pubmed-8649067
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86490672021-12-17 Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients Aghahowa, S.E. Ozolua, R.I. Bafor, E.E. Obarisiagbon, P. Isah, A.O. Toxicol Rep Regular Article BACKGROUND: Following the paucity of safety reports in the use of Artemisinin-Based Combination Therapies (ACTs) plus paracetamol, the study assessed safety potential of artemether-lumefantrine (ALP), artesunate-amodiaquine (AAP), artesunate-mefloquine (AMP), artesunate-sulphadoxine-pyrimethamine (ASPP) and dihydroartemisinin-piperaquine (DHPP) combination with paracetamol in malaria patients. METHODS: ACTs and paracetamol were administered concomitantly in conventional doses/regimen to randomly selected patients. Blood samples were collected from the ante-cubital vein before and after completion of therapies. Toxicity markers such as weights, glucose, lipids, renal electrolytes, liver enzymes and haematological indices were assessed using standard protocols. RESULTS: The total numbers of participants were 57 patients. Male to female ratio was 1:1.1. Mean body weight and ages were 59.19 ± 1.39 kg and 42.86 ± 1.32 years respectively. The mean temperatures prior to and after therapy were 37.49 ± 1.02 °C and 37.50 ± 0.17 °C respectively. Mean parasitaemia before the commencement of therapy was 6282 ± 21.01 parasites/μl. Out of thirty-seven toxicological indices evaluated, twenty–four were significantly altered by ACTs plus paracetamol (P < 0.05). Increased serum toxicity markers due to the drug combinations were glucose (AAP, AMP), urea (ALP, ASPP), bicarbonate ion (ALP, AAP, AMP, ASPP), chloride ion (ALP, AAP, AMP), creatinine (ALP, AAP, AMP, ASPP), alkaline phosphatase (ALP, AAP), aspartate aminotransferase and alanine aminotransferase (ALP, AAP, AMP, ASPP, DHPP), total protein (AMP, DHPP) and albumin (AMP, DHPP). Decreased serum toxicity markers due to the drugs were glucose (ALP, ASPP, DHPP), urea (AMP), bicarbonate ion (DHPP), chloride ion (ASPP, DHPP), creatinine (DHPP), alkaline phosphatase (AMP, ASPP, DHPP), total protein (ALP, AAP, and ASPP) and albumin (ALP, AAP, ASPP). Altered haematological indices were white blood cells, red blood cells, mean cell haemoglobin and platelets. CONCLUSION: Since ACTs plus paracetamol altered human system, discrete selection is essential in managing uncomplicated malaria most especially in patients with co-morbid conditions. Elsevier 2021-11-25 /pmc/articles/PMC8649067/ /pubmed/34926171 http://dx.doi.org/10.1016/j.toxrep.2021.11.007 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Aghahowa, S.E.
Ozolua, R.I.
Bafor, E.E.
Obarisiagbon, P.
Isah, A.O.
Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients
title Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients
title_full Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients
title_fullStr Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients
title_full_unstemmed Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients
title_short Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients
title_sort toxicological effect of artemisinin-based combination therapies plus paracetamol in malaria patients
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649067/
https://www.ncbi.nlm.nih.gov/pubmed/34926171
http://dx.doi.org/10.1016/j.toxrep.2021.11.007
work_keys_str_mv AT aghahowase toxicologicaleffectofartemisininbasedcombinationtherapiesplusparacetamolinmalariapatients
AT ozoluari toxicologicaleffectofartemisininbasedcombinationtherapiesplusparacetamolinmalariapatients
AT baforee toxicologicaleffectofartemisininbasedcombinationtherapiesplusparacetamolinmalariapatients
AT obarisiagbonp toxicologicaleffectofartemisininbasedcombinationtherapiesplusparacetamolinmalariapatients
AT isahao toxicologicaleffectofartemisininbasedcombinationtherapiesplusparacetamolinmalariapatients